Conflicts on HHS stem cell council

Nearly half the voting members of a Department of Health and Human Services linkurl:stem cell;http://www.the-scientist.com/article/display/54071/ advisory council have financial conflicts of interest despite the committee's pledge to limit these types of conflicts, according to a linkurl:survey;http://www.cspinet.org/integrity/watch/200804281.html#1 conducted by a science watchdog group. The Center for Science in the Public Interest polled the 25 voting members of HHS's linkurl:Advisory Council

Bob Grant
Bob Grant

Bob Grant is Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.

View full profile.


Learn about our editorial policies.

Apr 27, 2008
Nearly half the voting members of a Department of Health and Human Services linkurl:stem cell;http://www.the-scientist.com/article/display/54071/ advisory council have financial conflicts of interest despite the committee's pledge to limit these types of conflicts, according to a linkurl:survey;http://www.cspinet.org/integrity/watch/200804281.html#1 conducted by a science watchdog group. The Center for Science in the Public Interest polled the 25 voting members of HHS's linkurl:Advisory Council on Blood Stem Cell Transplantation;http://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/index.html (ACBSCT) and found that 11 reported having financial ties to stem cell and linkurl:umbilical cord blood;http://www.the-scientist.com/2007/03/01/s62/1/ banking companies, drug makers, and the linkurl:transplantation;http://www.the-scientist.com/article/display/17367/ industry. For example, linkurl:Frederick Appelbaum,;http://myprofile.cos.com/APPELBAUM who is the head of medical oncology at the University of Washington, has relationships with Merck, Bristol-Myers Squibb, Wyeth, and Genzyme. Another council member, linkurl:Richard Champlin,;http://www.mdanderson.org/departments/bmt/display.cfm?id=627c8063-8efd-11d4-80fa00508b603a14&method=displayfull&pn=d1766775-8e4c-11d4-80fa00508b603a14 is the chairman of the University of Texas in Houston's Stem Cell Transplantation and Cellular Therapy Department, but also serves on the medical advisory board of linkurl:Stemcyte,;http://www.the-scientist.com/article/display/15348/ an international company that runs...
sory council have financial conflicts of interest despite the committee's pledge to limit these types of conflicts, according to a linkurl:survey;http://www.cspinet.org/integrity/watch/200804281.html#1 conducted by a science watchdog group. The Center for Science in the Public Interest polled the 25 voting members of HHS's linkurl:Advisory Council on Blood Stem Cell Transplantation;http://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/index.html (ACBSCT) and found that 11 reported having financial ties to stem cell and linkurl:umbilical cord blood;http://www.the-scientist.com/2007/03/01/s62/1/ banking companies, drug makers, and the linkurl:transplantation;http://www.the-scientist.com/article/display/17367/ industry. For example, linkurl:Frederick Appelbaum,;http://myprofile.cos.com/APPELBAUM who is the head of medical oncology at the University of Washington, has relationships with Merck, Bristol-Myers Squibb, Wyeth, and Genzyme. Another council member, linkurl:Richard Champlin,;http://www.mdanderson.org/departments/bmt/display.cfm?id=627c8063-8efd-11d4-80fa00508b603a14&method=displayfull&pn=d1766775-8e4c-11d4-80fa00508b603a14 is the chairman of the University of Texas in Houston's Stem Cell Transplantation and Cellular Therapy Department, but also serves on the medical advisory board of linkurl:Stemcyte,;http://www.the-scientist.com/article/display/15348/ an international company that runs cord blood banking programs. According to the Center for Science in the Public Interest, the HHS official in charge of the ACBSCT said that none of the initial applicants to the council (of which there were over 100) were screened for conflicts of interest even though the council's linkurl:charter;http://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/Charter/index.html clearly states that, "Any member of the Council who has an employment, governance, or financial affiliation with a donor center, recruitment organization, transplant center, or cord blood bank will be prohibited from participating in any decision that materially affects the donor center, recruitment organization, transplant center, or cord blood bank. The number of members with such affiliations on the Council shall be limited." The ACBSCT was formed in 2006 to advise HHS policy makers on cord blood donation and stem cell transplantation science and met for the first time this past January. The council is meeting today and tomorrow (Apr 28 and 29) in Rockville, Maryland to discuss cord blood donor recruitment practices, blood bank accreditation, and linkurl:stem cell transplantation;http://www.the-scientist.com/article/daily/24908/ practices.

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?